Comparative analysis of sporadic cases and family form of progressive muscular atrophy over a 30-year period (1986-2016) in the Republic Sakha (Yakutia)
https://doi.org/10.25789/YMJ.2018.64.34
Abstract
Progressive muscle atrophy (PMA) is a rare disease of the motor neuron disease group (MND), which is characterized by selective lesions of the anterior horns of the spinal cord.
Objective: to study the features of the course of sporadic and family form of PMA over the period from 1986 to 2016.
Materials and methods: in 2006, a personalized register was introduced, which included patients with MND (amyotrophic lateral sclerosis, progressive muscular atrophy, progressive bulbar paralysis, primary lateral sclerosis). Since 1986 till 2006 patients were introduced after a retrospective study. The study included 15 patients with sporadic form and 5 patients from the same family. For the described study, patients with PMA were divided into 2 groups: 1 group included sporadic cases of progressive muscle atrophy (n=16), 2 group consisted of sick family members of a family case of 2 women and 2 men (n=4). Clinical examination of patients included assessment of somatic and neurological status in the onset of the disease and its further development, age of onset and duration of course.
Research methods: needle electromyography (EMG), Amyotrophic lateral Sclerosis Functional Rating Scale (ALSFRS) [9], spirography (LNG), forced vital capacity (FVC), magnetic resonance imaging (MRI), computed tomography (CT) of brain and spinal cord. In 9 cases, direct DNA diagnosis was carried out to exclude Kennedy’s Bulbo-spinal amyotrophy.
Results: Our study revealed a moderate rate of progression in sporadic cases and a slow rate of progression in the family form of PMA. In our study, the duration of PMA was significantly higher in the family form and was 140±37.8 and 53.6±30.3 months in sporadic cases (p =0.003). In the family form of the disease, an earlier age of debut was observed than in sporadic PMA and in men the disease began earlier than in women.
About the Authors
T. K. DavydovaRussian Federation
Davydova Tatyana Kimovna, PhD, senior researcher of the Department of inflammatory and degenerative diseases of the brain Research Institute of health NEFU
677010, Yakutsk, Sergelyakhskoe highway 4 km, building C2
8 - 924 - 662- 0321
T. Ya. Nikolaeva
Russian Federation
Nikolaeva Tatyana Yakovlevna, MD, Professor, head of the Department of nervous diseases and psychiatry
Yakutsk
8-914-266-11-14
L. T. Okoneshnikova
Russian Federation
Okoneshnikova Lyudmila Timofeevna, head of the neurological Department
677005, Yakutsk, P. Alekseeva str. 83A, 89142858181
References
1. Andersen P.M. Genetics of amyotrophic lateral sclerosis / P.M. Andersen // S.S. Korsakov Zourn. Neurology and Psychiatry. – 2001. – № 3. – p. 54-634.
2. Davydova T.K. Clinical and epidemiological characteristics of amyotrophic lateral sclerosis in the Republic of Sakha (Ya): PhD diss.: protected on 10/28/11: approved on 03/04/2011 / T. K. Davydova. – Irkutsk, 2010.-139 p.
3. Davydova T.K. Experience of differential diagnosis of Kennedy spinal-bulbar amyotrophy and the familial form of motor neuron disease in the RS (Ya) / T.K. Davydova, F.A. Platonov, T.E. Popova // Yakut Medical Journal .– 2014. -№ 2. – p. 19-23.
4. Davydova T.K. Features of the familial form of amyotrophic lateral sclerosis in Yakutia /Т.К. Davydova // Yakut Medical Journal. – 2009.-№4. – pp. 63-65.
5. Limb-girdle muscular dystrophy with autosomal dominant type of inheritance: pelviofemoral form of Leiden – Moebius / N.А. Schneider, T.Ya. Nikolaeva, E.N. Boroeva [et al.] // Neuromuscular Diseases. – 2013.– №1.– P.56-71.
6. Levitsky G.N. Amyotrophic lateral sclerosis – treatment and theoretical issues / G.N. Levitsky. – M.: Practical medicine, 2010. – 457 p.
7. Skvortsova V.I. Modern ideas about the etiology, pathogenesis and treatment of motor neuron disease / V.I. Skvortsova, S.A. Limborskaya, G.N. Levitsky // S.S. Korsakov Zourn. Neurology and Psychiatry. – 2005.– №1. – p. 4-12.
8. Kennedy s disease: a clinicopathologic correlation with mutations in androgen receptor gene / A.A. Amato, T.W. Prior, R.J. Barohn [et al.] // J. Neurology.– 1993.– p. 43: 791-794.
9. Mamede de C. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis? / C. de Mamede, M. Swash //Archives of neurology. -2006. – Vol. 63. – №4. – P. 557-560.
10. Shipe C. Electrodiagnostic evaluation of motor neuron disorders / C. Shipe, S.A. Zivkovic //Am J. END Technol 2004; 44: 30-36
11. Study of 962 patients indicates progressive muscular atrophy is a form of ALS / W.K. Kim, X. Liu, J. Sandner [et al.] // J. Neurology. – 2009; Nov 17; 73 (20):1686-92.
12. Word Federation of Neurology Research Group on Neuromuscular Diseases: Classification of 1994 Neuromuscular disorders // J. Neurol. Sci., 1994. – №124. – P.109-1302.
Review
For citations:
Davydova T.K., Nikolaeva T.Ya., Okoneshnikova L.T. Comparative analysis of sporadic cases and family form of progressive muscular atrophy over a 30-year period (1986-2016) in the Republic Sakha (Yakutia). Yakut Medical Journal. 2018;(4):110-113. https://doi.org/10.25789/YMJ.2018.64.34